diagnosis

Distributed by
Thoracent, a Maverix company
Sales inquiries
Customer Care
customercare@thoracent.com
About

An accurate diagnosis starts with adequate tissue.

Maverix offers a suite of endobronchial instruments for interventional pulmonologists — from forceps for histological sampling of the airway wall, to ultrasound-guided needles for submucosal and extramural targets, to a cryoprobe that takes tissue biopsies by cryoadhesion and removes foreign bodies, mucus plugs, clots, and necrotic tissue.

Products
Narwhal Cryo System

Narwhal Cryo System

Learn more
EBUS Needles

EBUS Needles

Learn more
Biopsy Forceps

Biopsy Forceps

Learn more
Featured
Maverix Narwhal Cryo System

The Future
of Cryobiopsy.

A single-use, completely disposable, console-free cryobiopsy probe — handheld and self-contained, with selectable sampling lengths and no cryo console to purchase or service.

Explore the Narwhal Cryo System
Narwhal cryoprobe tip
Design innovations for efficiency and control

No capital equipment.

Narwhal probe with its single-use Cryo cartridge
Why it matters

Handheld and self-contained. Each probe is powered by a single-use Cryo cartridge, freeing cryobiopsy from a fixed console — simplifying setup and use.

Pointed tip.

Pointed, radiopaque cryoprobe tip
Why it matters

A pointed, radiopaque cryoprobe tip facilitates direct access for efficient biopsy sampling.

All-in-one adjustable tip length.

Integrated tip-length adjustment dial, 3 mm or 6 mm
Why it matters

Selectable tip length puts the physician in control. An integrated adjustment dial offers short (~3 mm) or long (~6 mm) options, allowing sample size matching to the target.

Backed by preclinical testing

Building a strong clinical foundation.

In our preclinical animal studies, the Maverix Narwhal cryobiopsy probe met every predefined endpoint for performance and safety, capturing high-quality samples with no clinically significant bleeding or pneumothorax observed. (37 biopsy samples across 3-, 5-, and 7-second freeze times)

100%

All predefined performance endpoints met.

0

Pneumothorax observed or major bleeding events.*

7.3mg3 mm12.4mg6 mm

Average biopsy sample weight by sampling length.

Data on file at Maverix. Predefined performance endpoints: avulsion success rate, biopsy weight, usability, bleeding, pneumothorax, gross necropsy, histological accessibility, and percent artifact-free biopsy samples. Fluoroscopy time and radiation dose were also characterized in this analysis. *Minor bleeding was observed in some samplings; it was not clinically significant, met the pre-determined acceptance criteria, and was statistically the same as the comparison device. As with any cryosurgical procedure, bleeding and pneumothorax are potential risks — refer to the Instructions for Use. Preclinical results may not be representative of clinical performance.

All devices are prescription-only, for use by trained physicians. See each product’s Instructions for Use for complete indications, contraindications, warnings, and precautions.